Resources Contact Us Home Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE     Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety Image Number 13 for United States Patent #8119616. The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a .beta.-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.       Recently Added Patents Tetrazolyl oxime derivative, salt thereof, and plant disease control agent Cylindrical lithium secondary battery comprising a contoured center pin Electro-optical device, method of manufacturing the same, and electronic apparatus Method and system for distributing ringback files Knife grip Negative active material for a rechargeable lithium battery, a method of preparing the same, and a rechargeable lithium battery comprising the same Image forming apparatus   Randomly Featured Patents Range-finding method and apparatus Method for reducing the content of spurious signals in the output signals of a mixer, and mixer for carrying out the method Protection for spacecraft Method for annealing domain wall displacement type magneto-optical disc and magneto-optical disc Process for the preparation of aldehydes by hydroformylation of olefins Method and apparatus for serving and displaying food Method and apparatus for packaging flip chip bare die on printed circuit boards Top-loading stapler Imaging apparatus with three dimensional circuit board (2-quinoxalinyloxy) phenoxypropanoic acids and related derivatives as anticancer agents © 2006-2008 PatentGenius. All Rights Reserved.